12.05.25 -- GCP Oversight Simplified: A Quick Guide

Explore how AI can help overcome key challenges in hepatology trials — from site selection and patient matching to data integration and engagement — while ensuring diversity, privacy, and transparency.

Rare neurological trials face ethical and operational barriers. Natural history studies and external control arms provide accepted, practical alternatives to de-risk development and accelerate patient access.

AI is reshaping clinical trials by accelerating patient recruitment, optimizing protocol design, and improving data quality—driving faster, more efficient, and more inclusive research outcomes.

Uncover how a collaboration supported timely progress toward key study milestones, enabling smoother execution and more dependable output across data management and statistical activities.

Speakers delve into how AI is reshaping every stage of the clinical trial journey — from designing smarter, more feasible protocols to streamlining study start-up and execution.

Real-world data (RWD) is transforming colorectal cancer research by complementing traditional clinical trials, accelerating drug development, and improving patient outcomes.

Learn how biotech firms can harness emerging technologies and other AI-driven innovations to shape the future of data-powered healthcare and scientific discovery.

The ISPOR Education Center provides access to Health Economics and Outcomes Research (HEOR) education with on-demand programs delivered through a personalized and flexible learning platform.

A structured, stable, and robust environment for collaboration enables secure real-time document review, co-authoring, and redaction in order to shorten the document review process by up to 65%.

Learn how to adopt artificial intelligence in practical, measurable ways, from protocol feasibility and cohort modeling to clinical trial disclosure and transparency.

Increasingly complex clinical trials require a fast, flexible data and analytics platform. See how access to real-time data is able to drive analytic efficiencies and bring new drugs to market faster.